About recombina nt human interferon
Recombinant human interferon gamma
Used for
- Treatment of chronic granulomatous disease to reduce serious infections.
- Treatment of severe malignant osteopetrosis to reduce serious infections.
Usual adult dose
50 micrograms/m² under the skin three times weekly; dosing depends on the condition.
Usual dose in children
50 micrograms/m² under the skin three times weekly; infants under one year generally receive 1.5 micrograms/kg.
Common side effects
- Fever, chills, headache, and fatigue
- Muscle or joint pain
- Injection-site redness or tenderness
- Nausea or vomiting
Important warnings
- May worsen heart, liver, or kidney problems.
- Can lower blood counts; monitoring may be needed.
- Use caution with seizure disorders or bone-marrow suppression.
- Serious allergic reactions are possible.
Pregnancy
Human pregnancy data are limited; use only when the expected benefit outweighs potential risk.
Breastfeeding
It is not known whether interferon gamma enters breast milk; consult product labeling.
Interactions
- Medicines that suppress bone marrow may increase blood-count problems.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.